Corrigendum to “Synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide: Evidence for inhibition of activated MAPKs/NF-κB and reduced cell proliferation” [Food Chem. Toxicol. 49 (2011) 1511–20](S0278691511001232)(10.1016/j.fct.2011.03.040);Synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide: Evidence for inhibition of activated MAPKs/NF-κB and reduced cell proliferation

Food and Chemical Toxicology

Volumn 49, Issue 7, 2011, Pages 1511-1520

  George, Jasmine ^a   Singh, Madhulika ^a   Srivastava, Amit Kumar ^a   Bhui, Kulpreet ^a   Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Chemoprevention; Diallyl sulfide; Mechanism; Mouse skin tumors; Pomegranate fruit extract; Synergy

Indexed keywords

ALLYL SULFIDE; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; POMEGRANATE EXTRACT; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER INCIDENCE; CANCER INHIBITION; CANCER STAGING; CARCINOGENICITY; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN TUMOR; TUMOR REGRESSION; TUMOR VOLUME;

LYTHRACEAE;

EID: 79957629293     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2019.110784     Document Type: Erratum

References (56)

1. Adams L.S., Seeram N.P., Aggarwal B.B., Takada Y., Sand D., Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food. Chem. 2006, 54:980-985.
2. Adderley S.R., Fitzgerald D.J. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J. Biol. Chem. 1999, 274:5038-5046.
3. Adhami V.M., Malik A., Zaman N., Sarfaraz S., Siddiqui I.A., Syed D.N., Afaq F., Pasha F.S., Saleem M., Mukhtar H. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin. Cancer Res. 2007, 5:1611-1619.
4. Afaq F., Adhami V.M., Ahmad N., Mukhtar H. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate. Oncogene 2003, 22:1035-1044.
5. Afaq F., Saleem M., Krueger C.G., Reed J.D., Mukhtar H. Anthocyanins- and hydrolysable tannin-rich pomegranate fruit extract modulates MAPK and NF-κB pathway and inhibits skin tumorigenesis in CD-1 mice. Int. J. Cancer 2005, 113:423-433.
6. Aggarwal B.B., Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006, 10:1397-1421.
7. Arora A., Shukla Y. Induction of apoptosis by diallyl sulfide in DMBA-induced mouse skin tumors. Nutr. Cancer 2002, 1:89-94.
8. Arora A., Siddiqui I.A., Shukla Y. Modulation of p53 in 7, 12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice. Mol. Cancer Ther. 2004, 3:1459-1466.
9. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
10. Bharti A.C., Aggarwal B.B. Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. Ann. N.Y. Acad. Sci. 2002, 973:392-395.
11. Bhuvaneswari V., Abraham S.K., Nagini S. Combinatorial antigenotoxic and anticarcinogenic effects of tomato and garlic through modulation of xenobiotic-metabolizing enzymes during hamster buccal pouch carcinogenesis. Nutrition 2005, 21:726-731.
12. Bogovaski, P., 1973. Tumours of skin. In: Turusov, V.S., (Ed.), Pathology of Tumours in Laboratory Animals. IARC Scientific Publication No. 23, Lyon, pp. 1-14.
13. Chou T.C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 1984, 22:27-55.
14. Chun K.S., Keum Y.S., Han S.S., Song Y.S., Kim S.H., Surh Y.J. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 2003, 24:1515-1524.
15. Dausch J.G., Nixon D.W. Garlic: a review of its relationship to malignant disease. Prev. Med. 1990, 19:346-361.
16. de Kok T.M., van Breda S.G., Manson M.M. Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur. J. Nutr. 2008, 2:51-59.
17. Dorant E., van den Brandt P.A., Goldbohm R.A., Hermus R.J., Sturmans F. Garlic and its significance for the prevention of cancer in humans: a critical view. Br. J. Cancer 1993, 67:424-429.
18. Drobiova H., Thomson M., Al-Qattan K., Peltonen-Shalaby R., Al-Amin Z., Ali M. Garlic increases antioxidant levels in diabetic and hypertensive rats determined by a modified peroxidase method. Evid. Based Complement. Altern. Med. 2009, 2011:1-8.
19. Fleischauer A.T., Poole C., Arab L. Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers. Am. J. Clin. Nutr. 2000, 72:1047-1052.
20. Frenkel K., Wei L., Wei H. 7, 12-dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic. Biol. Med. 1995, 3:373-380.
21. Garg A., Aggarwal B.B. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002, 16:1053-1068.
22. Gil M.I., Tomas-Barberan F.A., Hess-Pierce B., Holcroft D.M., Kader A.A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food. Chem. 2000, 48:4581-4589.
23. Guo S., Deng Q., Xiao J., Xie B., Sun Z. Evaluation of antioxidant activity and preventing DNA damage effect of pomegranate extracts by chemiluminescence method. J. Agric. Food. Chem. 2007, 8:3134-3140.
24. Hall P.A., Levison D.A., Woods A.L., Yu C.C.W., Kellock D.B., Watkins J.A. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 1990, 162:285-294.
25. Israel A. A role for phosphorylation and degradation in the control of NF-kappa B activity. Trends Genet. 1995, 11:203-205.
26. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18:621-663.
27. Karmakar S., Banik N.L., Patel S.J., Ray S.K. Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Apoptosis 2007, 12:671-684.
28. Kataoka K., Kim D.J., Carbajal S., Clifford J.L., DiGiovanni J. Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis 2008, 6:1108-1114.
29. Kaur G., Jabbar Z., Athar M., Alam M.S. Punica granatum (pomegranate) flower extract possesses potent antioxidant activity and abrogates Fe-NTA induced hepatotoxicity in mice. Food Chem. Toxicol. 2006, 44:984-993.
30. Kennedy N.J., Cellurale C., Davis R.J. A radical role for p38 MAPK in tumor initiation. Cancer Cell 2007, 2:101-103.
31. Khafif A., Schantz S.P., Chou T.C., Edelstein D., Sacks P.G. Quantitation of chemopreventive synergism between epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant oral epithelial cells. Carcinogenesis 1998, 19:419-424.
32. Kim N.D., Mehta R., Yu W., Neeman I., Livney T., Amichay A., Poirier D., Nicholls P., Kirby A., Jiang W., Mansel R., Ramachandran C., Rabi T., Kaplan B., Lansky E. Chemoprevetive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res. Treat. 2002, 71:203-217.
33. Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis 1990, 21:485-495.
34. Lowry O.H., Rosenbrough N.K., Farr A.L. Protein measurement with folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
35. Malik A., Afaq F., Sarfaraz S., Adhami V.M., Syed D.N., Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc. Natl Acad. Sci. USA 2005, 102:14813-14818.
36. Mancini R., Marucci L., Benedetti A., Jezequel A.M., Orlandi F. Immunohistochemical analysis of S-phase cells in normal human and rat liver by PC10 monoclonal antibody. Liver 1994, 2:57-64.
37. Maniatis T. Catalysis by a multiprotein IkappaB kinase complex. Science 1997, 278:818-819.
38. Nagini S. Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise?. Anticancer Agents Med. Chem. 2008, 3:313-321.
39. Nigam N., Shukla Y. Preventive effects of diallyl sulfide on 7, 12-dimethylbenz[a]anthracene induced DNA alkylation damage in mouse skin. Mol. Nutr. Food Res. 2007, 51:1324-1328.
40. Noda Y., Kaneyuki T., Mori A., Packer L. Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J. Agric. Food. Chem. 2002, 1:166-171.
41. Pacheco-Palencia L.A., Noratto G., Hingorani L., Talcott S.T., Mertens-Talcott S.U. Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts. J. Agric. Food Chem. 2008, 18:8434-8441.
42. Pantuck A.J., Zomorodian N., Belldegrun A.S. Phase-II Study of prostate cancer and increasing PSA. Curr. Urol. Rep. 2006, 7:7.
43. Sarfaraz S., Siddiqui I.A., Syed D.N., Afaq F., Mukhtar H. Guggulsterone modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in SENCAR mice. Carcinogenesis 2008, 10:2011-2018.
44. Seeram N.P., Adams L.S., Henning S.M., Niu Y., Zhang Y., Nair M.G., Heber D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J. Nutr. Biochem. 2005, 16:360-367.
45. Sengupta A., Ghosh S., Das S. Tomato and garlic can modulate azoxymethane-induced colon carcinogenesis in rats. Eur. J. Cancer Prev. 2003, 3:195-200.
46. Serpi R., Piispala J., Jarvilehto M., Vahakangas K. Thapsigargin has similar effect on p53 protein response to benzo(a)pyrene DNA adducts as TPA in mouse skin. Carcinogenesis 1999, 20:1755-1760.
47. Singh A., Shukla Y. Antitumor activity of diallyl sulfide in two-stage mouse skin model of carcinogenesis. Biomed. Environ. Sci. 1998, 11:258-263.
48. Singh R.P., Chidambara Murthy K.N., Jayaprakasha G.K. Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models. J. Agric. Food. Chem. 2002, 50:81-86.
49. Singh R.P., Tyagi A.K., Zhao J., Agarwal R. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis 2002, 3:499-510.
50. Sriram N., Kalayarasan S., Ashokkumar P., Sureshkumar A., Sudhandiran G. Diallyl sulfide induces apoptosis in Colo 320 DM human colon cancer cells: involvement of caspase-3, NF-kappaB, and ERK-2. Mol. Cell. Biochem. 2008, 1-2:157-165.
51. Takada Y., Aggarwal B.B. Flavopiridol inhibits NF-κB activation induced by various carcinogens and inflammatory agents through inhibition of Ikappa Balpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2 and matrix metalloprotease-9. J. Biol. Chem. 2004, 279:4750-4759.
52. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:456-462.
53. Wu C.C., Sheen L.Y., Chen H.W. Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats. J. Food Chem. Agri. 2002, 50:378-383.
54. Xiao D., Choi S., Lee Y.J., Singh S.V. Role of mitogen-activated protein kinases in phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells. Mol. Carcinog. 2005, 3:130-140.
55. Zhou J.R., Yu L., Zhong Y., Blackburn G.L. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J. Nutr. 2003, 133:516-521.
56. Zoumpourlis V., Solakidi S., Papathoma A., Papaevangeliou D. Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis. Carcinogenesis 2003, 24:1159-1165.